IP Library Patent Application 15482505
Patent Application
App. No. 15/482,505

EQUINE PARASITE TREATMENT METHODS AND COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/482,505
Abstract

New compositions and methods are provided for controlling a parasitic infection in a horse through administration of an effective amount of D. flagrans . In certain aspects, multiple, distinct strains of D. flagrans are administered. In additional aspects, the amount and treatment regimen of D. flagrans administered to a horse is based on one or more pre-identified characteristics of the horse, is combined with additional therapeutic agents for more comprehensive parasite control, or is accomplished via custom made, pre-measured daily dose packages. In another aspect, compositions and methods are provided that comprise combined use of 1) D. flagrans and 2) one or more insect growth regulators.

Claims (27)

1 . A method for treating or controlling a parasitic infection in a mammal, comprising:

administering to the mammal an effective amount of D. flagrans selected for the mammal to control a parasitic infection.

2 . A method for treating or controlling a parasitic infection in a mammal comprising:

administering to the mammal an effective amount of multiple, distinct strains of D. flagrans.

3 . The method of claim 1 wherein the mammal is a horse.

4 . The method of claim 1 wherein the mammal is a livestock animal.

5 . The method of claim 1 wherein the administered D. flagrans passes through the digestive tract of the mammal, resides in the subject's manure and therein captures infective parasites.

6 . The method of claim 1 wherein the mammal has been identified as susceptible to or suffering from a small strongyles (equine cyathostomin) and/or large strongyles infection.

7 . The method of claim 1 wherein the administered amount of D. flagrans has been selected based on one or more characteristics of the mammal.

8 . The method of claim 1 wherein the administered D. flagrans had been packaged based on one or more previously identified characteristics of the mammal.

9 . The method of claim 1 wherein the administered D. flagrans had been packaged together with additional feed and/or therapeutic agents based on one or more previously identified characteristics of the mammal.

10 . The method of claim 1 wherein the one or more additional therapeutic agents are administered to the mammal in conjunction with the D. flagrans.

11 . The method of claim 1 wherein the D. flagrans and/or wherein the one or more additional therapeutic agents are administered to the mammal through custom made, pre-measured daily dose packages.

12 . The method of claim 9 wherein the one or more additional therapeutic agents are selected from a macrocyclic lactone, a pyrimidine, a benzimidazole, pyraziquantel, diatomaceous earth, an insect growth regulator, and/or parasite wasps.

13 . The method of claim 1 wherein the D. flagrans is administered to the mammal together with food.

14 . The method of claim 1 wherein the D. flagrans is administered to the mammal once per day.

15 . The method of claim 1 wherein the D. flagrans is administered to the horse multiple times per day.

16 . The method of claim 1 wherein the D. flagrans is administered to the horse multiple times per week for at least 30 consecutive weeks.

17 . A composition for administration to a horse or other mammal comprising multiple, distinct strains of D. flagrans.

18 . A packaged composition for administration to a horse or other mammal comprising an effective amount of one or more distinct strains of D. flagrans.

19 . The composition of claim 17 wherein the D. flagrans is packaged in an amount based on one or more previously identified characteristics of the mammal.

20 . The composition of claim 17 wherein the D. flagrans and additional feed and/or therapeutic agents are segregated within a unitary packaging.

21 . A method for treating or controlling a parasitic infection in a mammal, comprising:

administering to the mammal an effective amount one or more compositions comprising: 1) D. flagrans and 2) one or more insect growth regulators.

22 . The method of claim 21 wherein the one or more insect growth regulators are cyroazine and/or diflubenzuron.

23 . The method of claim 21 wherein the mammal is a horse.

24 . A composition for administration to a horse or other mammal comprising: 1) D. flagrans and 2) one or more insect growth regulators such as cyroazine and/or diflubenzuron.

Assignments (3)
CONFIRMATION OF TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS AT R/F 51257/0316 Recorded Mar 30, 2026
From: JPMORGAN CHASE BANK, N.A.
To: SMARTPAK EQUINE, LLC
Reel/Frame 075321/0428 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: SMARTPAK EQUINE, LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 051257/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: FLEMING, CASEY; GRAY, LYDIA; GISHOLT, PAAL
To: SMARTPAK EQUINE LLC
Reel/Frame 042996/0922 →